Should you buy Neuberger Berman High Yield Strategies Fund stock? (NYSE American:NHS). Let's see how it does in our automated value investing analysis system.
Advantages | Disadvantages |
---|---|
|
|
NHS Price (Neuberger Berman High Yield Strategies Fund stock price per share) |
$8.85 | |
PE Ratio versus Sector | 330% higher than other Financial stocks | |
PE Ratio versus Industry | 226% higher than other Asset Management stocks | |
Free Cash Flow Jitter | 0% | |
Dividend Yield | 14% | Shares Shorted | 6,955 |
Based on our analysis, we believe that you should not buy Neuberger Berman High Yield Strategies Fund right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.
Does Neuberger Berman High Yield Strategies Fund have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
Most Popular Articles
What are The Dow, S&P 500, and NASDAQ Indexes?
What Happened to the Stock Market Today?
What are Broker Fees (and how to pay less)?
Why Do Companies Pay Dividends?
What is Self-Directed Investing?